Get the Stockscreener App
5.56
10.32%
0.52
Foghorn Therapeutics Inc stock is traded at $5.56, with a volume of 160.36K.
It is up +10.32% in the last 24 hours and down -12.30% over the past month.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
See More
Previous Close:
$5.04
Open:
$5.06
24h Volume:
160.36K
Relative Volume:
1.32
Market Cap:
$314.31M
Revenue:
$34.16M
Net Income/Loss:
$-98.43M
P/E Ratio:
-2.3761
EPS:
-2.34
Net Cash Flow:
$-119.33M
1W Performance:
+11.65%
1M Performance:
-12.30%
6M Performance:
+6.31%
1Y Performance:
-25.97%
1-Day Range:
$5.06
$5.69
1-Week Range:
$4.75
$5.69
52-Week Range:
$2.9448
$10.25
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Name
Foghorn Therapeutics Inc
Sector
Industry
Phone
617-586-3100
Address
500 TECHNOLOGY SQUARE, CAMBRIDGE
Compare FHTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
5.56 | 288.30M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-23-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-30-25 | Initiated | B. Riley Securities | Buy |
| Sep-03-24 | Initiated | Jefferies | Buy |
| Aug-19-24 | Initiated | Evercore ISI | Outperform |
| Mar-28-23 | Initiated | BofA Securities | Buy |
| Jan-05-23 | Initiated | BMO Capital Markets | Outperform |
| Nov-22-21 | Initiated | H.C. Wainwright | Buy |
| Nov-17-20 | Initiated | Cowen | Outperform |
| Nov-17-20 | Initiated | Goldman | Buy |
| Nov-17-20 | Initiated | Morgan Stanley | Overweight |
| Nov-17-20 | Initiated | Wedbush | Outperform |
View All
Foghorn Therapeutics Inc Stock (FHTX) Latest News
Real time social sentiment graph for Foghorn Therapeutics Inc.2025 Market Outlook & Safe Entry Momentum Stock Tips - Newser
Statistical indicators supporting Foghorn Therapeutics Inc.’s strength2025 Trading Volume Trends & Weekly Top Gainers Alerts - Newser
How sentiment analysis helps forecast Foghorn Therapeutics Inc.2025 Year in Review & Fast Entry and Exit Trade Plans - Newser
Does Foghorn Therapeutics Inc. fit your quant trading modelWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Is Foghorn Therapeutics Inc. trending in predictive chart models2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Price action breakdown for Foghorn Therapeutics Inc.2025 Short Interest & Long-Term Safe Investment Plans - Newser
How to escape a deep drawdown in Foghorn Therapeutics Inc.Trade Entry Report & AI Enhanced Market Trend Forecasts - Newser
Using flow based indicators on Foghorn Therapeutics Inc.Price Action & High Accuracy Trade Alerts - Newser
Foghorn Therapeutics Inc. stock outlook for YEARJuly 2025 Intraday Action & Daily Oversold Bounce Ideas - Newser
Forecasting Foghorn Therapeutics Inc. price range with options dataJuly 2025 Sector Moves & Free Community Supported Trade Ideas - Newser
What high frequency data says about Foghorn Therapeutics Inc.Market Rally & Free Safe Capital Growth Stock Tips - Newser
Price Action Confirms Reversal in Foghorn Therapeutics Inc. Trend2025 Breakouts & Breakdowns & Low Risk High Reward Ideas - newsimpact.co.kr
Can volume confirm reversal in Foghorn Therapeutics Inc.Market Movers & AI Based Trade Execution Alerts - Newser
Will a bounce in Foghorn Therapeutics Inc. offer an exit2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Understanding Foghorn Therapeutics Inc.’s price movement2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
Using data filters to optimize entry into Foghorn Therapeutics Inc.2025 Volatility Report & AI Powered Market Trend Analysis - Newser
Sentiment analysis tools applied to Foghorn Therapeutics Inc.2025 Stock Rankings & Real-Time Volume Triggers - Newser
Will Foghorn Therapeutics Inc. bounce back from current supportWeekly Profit Recap & Daily Volume Surge Signals - Newser
Is Foghorn Therapeutics Inc. stock ready for a breakoutMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Real time alert setup for Foghorn Therapeutics Inc. performanceGlobal Markets & Stepwise Trade Execution Plans - Newser
How sensitive is Foghorn Therapeutics Inc. to inflationJuly 2025 Momentum & Verified Momentum Stock Ideas - newsyoung.net
Applying Wyckoff theory to Foghorn Therapeutics Inc. stockShort Setup & Real-Time Volume Triggers - Newser
Foghorn Therapeutics Inc.’s volatility index tracking explainedTrade Volume Summary & Reliable Price Breakout Alerts - Newser
Foghorn Therapeutics Inc. stock prediction for this week2025 Analyst Calls & Weekly High Momentum Picks - Newser
Can technical indicators confirm Foghorn Therapeutics Inc.’s reversalMarket Performance Summary & Risk Controlled Swing Alerts - Newser
How to recover losses in Foghorn Therapeutics Inc. stockWeekly Trade Recap & Safe Capital Preservation Plans - Newser
How Foghorn Therapeutics Inc. stock performs during market volatility2025 Major Catalysts & Consistent Profit Alerts - Newser
Top Risks to Consider Before Buying Foghorn Therapeutics Inc. StockQuarterly Profit Report & AI Based Buy/Sell Signal Reports - Newser
Automated trading signals detected on Foghorn Therapeutics Inc.2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Foghorn Therapeutics Inc (NASDAQ: FHTX) Rises 6.16% In Recent Trading, What’s Next? - stocksregister.com
Foghorn Therapeutics Inc Stock (FHTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Foghorn Therapeutics Inc Stock (FHTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Costa Carlos | Chief People Officer |
Sep 23 '24 |
Option Exercise |
3.72 |
857 |
3,188 |
857 |
| Costa Carlos | Chief People Officer |
Sep 20 '24 |
Sale |
10.04 |
35,756 |
358,990 |
0 |
| Costa Carlos | Chief People Officer |
Sep 23 '24 |
Sale |
10.17 |
857 |
8,716 |
0 |
| Costa Carlos | Chief People Officer |
Sep 18 '24 |
Option Exercise |
3.72 |
11,574 |
43,055 |
11,574 |
| Costa Carlos | Chief People Officer |
Sep 18 '24 |
Sale |
10.05 |
11,574 |
116,319 |
0 |
| Costa Carlos | Chief People Officer |
Sep 17 '24 |
Option Exercise |
3.72 |
10,272 |
38,212 |
10,272 |
| Costa Carlos | Chief People Officer |
Sep 16 '24 |
Option Exercise |
3.72 |
400 |
1,488 |
400 |
| Costa Carlos | Chief People Officer |
Sep 17 '24 |
Sale |
10.04 |
10,272 |
103,131 |
0 |
| Costa Carlos | Chief People Officer |
Sep 16 '24 |
Sale |
10.00 |
400 |
4,000 |
0 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):